LAILATULLAH BURGOS: Open Payments
NPI 1285785428 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 28 payments from 12 companies in 2025. Trend: 2023 $1,450 · 2024 $248 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $50 |
| ACADIA Pharmaceuticals Inc | 1 | $45 |
| Indivior Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
Products named: ARISTADA, Auvelity, COBENFY, INVEGA SUSTENNA, VRAYLAR, UZEDY, NUPLAZID, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
